Timbongan, Shenlee B.

HRN: 22-99-31  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/01/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/01/2023
05/07/2023
IV
500mg
Q8H
Infectious Diarrhea
Waiting Final Action 
05/01/2023
CEFTRIAXONE 1G (VIAL)
05/01/2023
05/07/2023
IV
2gms
OD
Infectious Diarrhea
Waiting Final Action 
05/03/2023
METRONIDAZOLE 500MG (TAB)
05/03/2023
05/09/2023
PO
500 Mg
TID
Infectious Diarrhea
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: